BSE: 532649|NSE: NECLIFE|ISIN: INE023H01027|SECTOR: Pharmaceuticals
Business News on Nectar Lifesciences
Expect double-digit growth in FY15: Nectar Life
12.33 pm | 22 Aug 2014 | Source: CNBC-TV18
In an interview to CNBC-TV18, Dinesh Dua, CEO of Nectar Lifesciences details the Q1 performance of the company and what he expects in the future. ...
Quick Links for Nectar Lifesciences
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.